New weight loss pill beats oral Ozempic in major trial

A new weight-loss pill, orforglipron, has outperformed the popular injectable drug Ozempic in a major clinical trial, showing superior weight loss and blood sugar control. This pill offers a more convenient option since it doesn't need refrigeration or precise meal timing, unlike its injectable counterparts. Additionally, it's cheaper to produce, potentially making it more accessible worldwide. This development could shift the landscape of weight management treatments, especially for those who find injections less appealing.